Long-term Durability Study of Collagenase Clostridium Histolyticum (CCH)
Clinical trial NCT04381117 · COMPLETED
Trial details
- NCT number
- NCT04381117
- Sponsor
- Endo USA Inc., a Keenova Therapeutics Company
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2020-05-06
- Primary completion
- 2020-06-22
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.